Publication | Closed Access

Phase II trial of the histone deacetylase inhibitor belinostat in women with platinum resistant epithelial ovarian cancer and micropapillary (LMP) ovarian tumours

Phase Ii TrialMedicineOvarian TumoursGynecologyCancer TreatmentOncologyRadiation OncologyTumor BiologyEndocrine-related CancerOvarian Cancer